Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrimidine compounds that inhibit anaplastic lymphoma kinase

Pyrimidine compounds that inhibit anaplastic lymphoma kinase

US Patent 8716281 · Granted May 6, 2014

Estimated economic value: $112,289,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Plasma kallikrein inhibitors2025
Compounds and methods of use2025
Inhibitors of receptor interacting protein kinase I for the treatment of disease2025
5-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors2025
6-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors2025
Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of JAK kinases2025
Method of treating or ameliorating metabolic disorders using GLP-1 receptor agon2025
EGFR inhibitors2024
MAP4K1 inhibitors2024
Compounds and methods of use2024
Substituted aminopyridine compounds as EGFR inhibitors2024
CDK2 inhibitors2024